VKTX Sep 2024 42.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:44PM EDT. Market open.
| Previous close | 11.57 |
| Open | 11.57 |
| Bid | 32.40 |
| Ask | 35.00 |
| Strike | 42.00 |
| Expiry date | 2024-09-20 |
| Day's range | 11.57 - 11.57 |
| Contract range | N/A |
| Volume | |
| Open interest | 8 |
ZacksShould You Hold Viking Therapeutics (VKTX) in Your Portfolio?
Viking Therapeutics' (VKTX) lead candidate for obesity, VK2735, is expected to have tremendous potential. However, existing competition from obesity drugs in the market remains a woe.
Simply Wall St.Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 72% of the company
Key Insights Significantly high institutional ownership implies Viking Therapeutics' stock price is sensitive to their...
Insider MonkeyViking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript April 24, 2024 Viking Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.27. Viking Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Viking […]
© 2024 Yahoo. All rights reserved.